Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 4/20 | 1.00 |
| ▸ | MGLL | Q99685 | 15/20 | 0.59 |
| ▸ | FAAH | O00519 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29510752 | 1.00 | HSP90AA1 (1.00) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL719070 | 0.94 | HSP90AA1 (0.89) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL723972 | 0.94 | HSP90AA1 (0.89) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL10411648 | 0.94 | HSP90AA1 (0.89) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL19512050 | 0.91 | HSP90AA1 (0.83) | HSP90AA1MGLLFAAHPKM | |
| SCHEMBL2928275 | 0.89 | HSP90AA1 (0.80) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL29405415 | 0.81 | HSP90AA1 (0.70) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL6396877 | 0.79 | HSP90AA1 (0.65) | HSP90AA1ALDH1A1LMNACYP1A2CYP2C9 | |
| SCHEMBL22862086 | 0.78 | HSP90AA1 (0.63) | HSP90AA1MGLLFAAHALDH1A1PKM | |
| SCHEMBL5769318 | 0.78 | HSP90AA1 (0.63) | HSP90AA1ALDH1A1LMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110317174-B | Hydrogen barrier agent, composition for forming hydrogen barrier film, method for producing hydrogen barrier film, and electronic device | 东京应化工业株式会社 | 2024-10-22 | — | — | CN | disclosed |
| CN-114432301-B | Covalent inhibitor derivative and application thereof in treatment of viral infection | 北京大学 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024053579-A1 | PHOTOSENSITIVE RESIN COMPOSITION | 東京応化工業株式会社 | 2024-03-14 | — | — | WO | disclosed |
| CN-117590696-A | Photosensitive resin composition | 东京应化工业株式会社 | 2024-02-23 | — | — | CN | disclosed |
| CN-116741789-A | Optical element for fingerprint authentication | 东京应化工业株式会社 | 2023-09-12 | — | — | CN | disclosed |
| US-20220389308-A1 | WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| EP-3998324-A1 | WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-05-18 | — | — | EP | disclosed |
| CN-113136239-B | Utilization method of ethylene cracking tar and application of compound containing carbon-carbon double bond | 清华大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-114432301-A | Covalent inhibitor derivative and application thereof in treating virus infection | 北京大学 | 2022-05-06 | — | — | CN | disclosed |
| CN-114127228-A | Wavelength conversion film, composition for forming wavelength conversion film, and method for producing cluster-containing quantum dot | 东京应化工业株式会社 | 2022-03-01 | — | — | CN | disclosed |
| US-9981914-B2 | — | — | 2018-05-29 | — | — | US | disclosed |
| US-20180086717-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| US-20130025495-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-01-31 | — | — | US | disclosed |
| WO-2011085281-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-07-14 | — | — | WO | disclosed |
| EP-1722781-A2 | MALEIIMIDE ANTI-TUMOR PHOSPHATASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-11-22 | — | — | EP | disclosed |
| EP-1697328-A1 | PYRAZOLINOLS USED AS PESTICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005081972-A2 | MALEIIMIDE ANTI-TUMOR PHOSPHATASE INHIBITORS | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-09-09 | — | — | WO | disclosed |
| WO-2005058838-A1 | PYRAZOLINOLS USED AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2005-06-30 | — | — | WO | disclosed |
| US-4427820-A | STYRENE, MALEIC ACID DERIVATIVE, EMULSION POLYMERIZATION | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-01-24 | — | — | US | disclosed |
| US-4127617-A | GRAFT POLYMER OF STYRENE-ACRYLONITRILE-A MALEIMIDE ON ETHYLENE-PROPYLENE-DIENE TERPOLYMER | ANIC, S.P.A. (IT) | 1978-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130025495-A1 | COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF | MEP1A, MACF1, CYP1B1 | HSP90AA1 1123/4885MGLL 1404/4885FAAH 2247/4885 |
| US-20180086717-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | SLC9A2, SLC9A1, NHERF1 | HSP90AA1 206/4885MGLL 1681/4885FAAH 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.